{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:20:56Z","timestamp":1787840456335,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"\n A\n BSTRACT<\/jats:sc>\n <\/jats:title>\n \n Background:<\/jats:title>\n Invasive fungal infections (IFIs) pose a significant risk specifically to the health of immunocompromised individuals, leading to a substantial number of deaths annually. Therapeutic options for IFIs are limited compared to bacterial infections, with only three classes of antifungal medications currently in use. The widespread use of triazole antifungals for IFI prevention and treatment, along with long treatment durations, has led to the emergence of severe drug resistance, indicating the urgent need for intervention to address this critical issue. This study aims to identify novel inhibitors for the Y140F\/H fungal CYP51 enzyme.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Molecular docking and molecular dynamics were utilized to evaluate 161 thiophene compounds for their inhibitory potential against the mutant CYP51.<\/jats:p>\n <\/jats:sec>\n \n Findings:<\/jats:title>\n The docking process involved two stages: docking on the wild type followed by docking on the mutant type, leading to the discovery of three compounds (referred to as compounds 1, 2, and 3) with better docking scores than the reference, indicating stronger binding affinity. Subsequent molecular dynamics simulations demonstrated that these three compounds displayed favorable stability and flexibility characteristics.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Based on our findings, we suggest that compounds 1, 2, and 3 have the potential to act as inhibitors of the Y140F\/H CYP51 enzyme.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_404_25","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:02:59Z","timestamp":1750208579000},"page":"S1888-S1893","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Novel Y140F\/H Mutant Fungal CYP51 Inhibitors: A Molecular Docking and Dynamics Study on Thiophene Compounds"],"prefix":"10.4103","volume":"17","author":[{"given":"Abdulrahim A.","family":"Alzain","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani 21111, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Edris","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani 21111, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rua M.","family":"Mukhtar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani 21111, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar M.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Analysis, Faculty of Medical and Health Sciences, Liwa University, Abu Dhabi 41009, United Arab of Emirates"},{"name":"Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek Abdullah","family":"Marzoqi Aldowimar","sequence":"additional","affiliation":[{"name":"Prince Mohammed Bin Abdulaziz Hospital-Al Madinah Al Munawarah-NGHA, Ministry of National Guard Health Affairs, Al Madinah Al Munawarah 41511, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Alqarni","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Ministry of National Guard-Health Affairs, Jeddah 22384, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrin R. M.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Preparatory Year Program, Batterjee Medical College, Jeddah, 21442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: Challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging new targets for the treatment of resistant fungal infections","volume":"61","author":"Liu","year":"2018","journal-title":"J Med Chem"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in candida albicans and emerging non- albicans Candida Species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"e0167485","DOI":"10.1371\/journal.pone.0167485","article-title":"Structural and functional elucidation of yeast lanosterol 14? -demethylase in complex with agrochemical antifungals","volume":"11","author":"Tyndall","year":"2016","journal-title":"PLoS One"},{"key":"R6-20250618","first-page":"1","article-title":"Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14?-demethylase","author":"Sagatova","year":"2016","journal-title":"Sci Rep"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of candida albicans sterol 14 ?-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J Biol Chem"},{"key":"R8-20250618","first-page":"539","article-title":"Thiophenes-naturally occurring plant metabolites: biological activities and in silico evaluation of their potential as cathepsin d inhibitors","volume":"11","author":"Ibrahim","year":"2022","journal-title":"Plants (Basel)"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11101-015-9403-7","article-title":"Naturally occurring thiophenes: Isolation, purification, structural elucidation, and evaluation of bioactivities","volume":"15","author":"Ibrahim","year":"2016","journal-title":"Phytochem Rev"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm Res"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"1339891","DOI":"10.3389\/fchem.2024.1339891","article-title":"Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: Pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies","volume":"12","author":"Alzain","year":"2024","journal-title":"Front Chem"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/metabo13050583","article-title":"Design of novel letrozole analogues targeting aromatase for breast cancer: Molecular docking, molecular dynamics, and theoretical studies on gold nanoparticles","volume":"13","author":"Edris","year":"2023","journal-title":"Metabolites"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/jof8050443","article-title":"Exploring the Activity of Fungal Phenalenone Derivatives as Potential CK2 Inhibitors Using Computational Methods","volume":"8","author":"Ibrahim","year":"2022","journal-title":"J Fungi (Basel)"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_404_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:23:13Z","timestamp":1787836993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_404_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":13,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_404_25","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2025-02-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}